^
Association details:
| Biomarker: | ICAM1 elevation |
|---|---|
| Cancer: | Solid Tumor |
| Drug Class: | PD1 inhibitor + PD-L1 inhibitor |
| Direction: | Resistant |
Evidence:
Source:
Title:
Early changes in soluble intracellular adhesion molecule-1 as prognostic biomarkers to immune checkpoint inhibitor
Published date:
06/14/2023
Excerpt:
Subgroup analysis indicated patients whose sICAM-1 significantly elevated had shorter PFS and OS in both anti-PD-1 and anti-PD-L1 treatment groups.
DOI:
10.1111/cts.13540
